Lakefront Biotherapeutics NV annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Lakefront Biotherapeutics NV Operating Margin Growth & History (LKFT)
Lakefront Biotherapeutics NV's operating margin was 26.53% for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 26.53% | +94.85 pp |
| 2024 | 2024-12-31 | −68.33% | −31.51 pp |
| 2023 | 2023-12-31 | −36.82% | +17.51 pp |
| 2022 | 2022-12-31 | −54.32% | +18.88 pp |
| 2021 | 2021-12-31 | −73.20% | −35.83 pp |
| 2020 | 2020-12-31 | −37.37% | −81.53 pp |
| 2019 | 2019-12-31 | 44.17% | +61.06 pp |
| 2018 | 2018-12-31 | −16.89% | +53.77 pp |
| 2017 | 2017-12-31 | −70.66% | −61.79 pp |
| 2016 | 2016-12-31 | −8.87% | +217.21 pp |
| 2015 | 2015-12-31 | −226.08% | — |
Lakefront Biotherapeutics NV quarterly operating margin
Q2.19
Q2.20
Q2.21
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2021 | 2021-06-30 | −33.45% | — |
| Q2 2020 | 2020-06-30 | −88.54% | — |
| Q2 2019 | 2019-06-30 | −75.53% | — |
Lakefront Biotherapeutics NV operating margin trends
Over the last five reported fiscal years, Lakefront Biotherapeutics NV's operating margin increased from −37.37% to 26.53%, a change of +63.89 percentage points. The latest reported quarter, Q2 2021, shows −33.45%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV filings at SEC.gov ↗